Sökning: "apolipoprotein A1"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden apolipoprotein A1.
1. Homocysteine and its determinants in relation to cardiovascular risk factors and myocardial infarction
Sammanfattning : Background: Globally, cardiovascular diseases (CVD), including myocardial infarction (MI) and stroke, are the leading cause of illness and death and constitute a significant part of the disease burden in Sweden and Western Europe. Age, hypertension, smoking, obesity, dyslipoproteinemia, diabetes, and impaired renal function are considered established risk factors for CVD. LÄS MER
2. Risk markers for a first myocardial infarction
Sammanfattning : The development of a first myocardial infarction is associated with a large number of contributing factors. Age, male sex, hypertension, smoking, diabetes, body mass index and hypercholesterolemia are considered as established risk factors. LÄS MER
3. Clinical Manifestations of Coronary Heart Disease and the Metabolic Syndrome : A Population-based Study in Middle-aged Men in Uppsala
Sammanfattning : During the past decades the knowledge concerning risk factors and pathophysiology of coronary heart disease (CHD) has substantially increased. However, despite identification of important risk factors CHD remains the leading cause of death in the western world. LÄS MER
4. Nutritional impact on health in patients with Rheumatoid Arthritis
Sammanfattning : Objective: Rheumatoid Arthritis (RA) is the most common autoimmune rheumatic disease, affecting around 0.5-1% of the population. The aim of this thesis was to study dietary impact on markers of health in patients with RA. Methods: Data from the randomized controlled crossover trial Antiinflammatory diet in Rheumatoid Arthritis (ADIRA) is used. LÄS MER
5. Addressing cardiovascular risk factors and therapy effects in rheumatoid arthritis : implications for atherosclerosis and cardiovascular disease
Sammanfattning : Rheumatoid arthritis (RA) is the prototype of chronic inflammatory disease associated with a 1.5-2 fold increased risk of cardiovascular disease (CVD) and premature mortality. LÄS MER